{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T18:11:18Z","timestamp":1758823878760},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T00:00:00Z","timestamp":1492473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1038\/pr.2017.39","type":"journal-article","created":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T16:04:41Z","timestamp":1492531481000},"page":"101-107","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pneumococcal vaccination and efficacy in patients with heterotaxy syndrome"],"prefix":"10.1038","volume":"82","author":[{"given":"Pei-Lan","family":"Shao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Hwan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jou-Kou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Wen","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuenn-Nan","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,18]]},"reference":[{"key":"BFpr201739_CR1","doi-asserted-by":"crossref","unstructured":"Park MK Cyanotic congenital heart defect: heterotaxia (atrial isomerism, splenic syndromes). In: Park MK, ed. Pediatric Cardiology for Practitioners. St. Louis, Mosby, 2008.","DOI":"10.1016\/B978-0-323-04636-7.50022-8"},{"key":"BFpr201739_CR2","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.ejcts.2008.12.018","volume":"35","author":"PV Anagnostopoulos","year":"2009","unstructured":"Anagnostopoulos PV, Pearl JM, Octave C et al, Improved current era outcomes in patients with heterotaxy syndromes. Eur J Cardiothorac Surg 2009;35:871\u20137 (discussion 877-8).","journal-title":"Eur J Cardiothorac Surg"},{"key":"BFpr201739_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1067\/mpd.2002.120510","volume":"140","author":"MH Wu","year":"2002","unstructured":"Wu MH, Wang JK, Lue HC . Sudden death in patients with right isomerism (asplenism) after palliation. J Pediatr 2002;140:93\u20136.","journal-title":"J Pediatr"},{"key":"BFpr201739_CR4","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1007\/s00246-010-9764-z","volume":"31","author":"TW Prendiville","year":"2010","unstructured":"Prendiville TW, Barton LL, Thompson WR, Fink DL, Holmes KW . Heterotaxy syndrome: defining contemporary disease trends. Pediatr Cardiol 2010;31:1052\u20138.","journal-title":"Pediatr Cardiol"},{"key":"BFpr201739_CR5","doi-asserted-by":"publisher","first-page":"99-104.e1","DOI":"10.1016\/j.jpeds.2013.08.051","volume":"164","author":"SN Chiu","year":"2014","unstructured":"Chiu SN, Shao PL, Wang JK et al, Severe bacterial infection in patients with heterotaxy syndrome. J Pediatr 2014;164:99-104.e1.","journal-title":"J Pediatr"},{"key":"BFpr201739_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/10245330600938463","volume":"12","author":"BM William","year":"2007","unstructured":"William BM, Thawani N, Sae-Tia S, Corazza GR . Hyposplenism: a comprehensive review. Part II: clinical manifestations, diagnosis, and management. Hematology 2007;12:89\u201398.","journal-title":"Hematology"},{"key":"BFpr201739_CR7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1445-5994.2007.01579.x","volume":"38","author":"D Spelman","year":"2008","unstructured":"Spelman D, Buttery J, Daley A et al, Guidelines for the prevention of sepsis in asplenic and hyposplenic patients. Intern Med J 2008;38:349\u201356.","journal-title":"Intern Med J"},{"key":"BFpr201739_CR8","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1365-2141.2011.08843.x","volume":"155","author":"JM Davies","year":"2011","unstructured":"Davies JM, Lewis MP, Wimperis J, Rafi I, Ladhani S, Bolton-Maggs PH . British Committee for Standards in H Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: prepared on behalf of the British Committee for Standards in Haematology by a working party of the Haemato-Oncology task force. Br J Haematol 2011;155:308\u201317.","journal-title":"Br J Haematol"},{"key":"BFpr201739_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1542\/pir.30-5-155","volume":"30","author":"SJ Alter","year":"2009","unstructured":"Alter SJ . Pneumococcal infections. Pediatr Rev 2009;30:155\u201364 (quiz 164).","journal-title":"Pediatr Rev"},{"key":"BFpr201739_CR10","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1128\/CMR.00018-12","volume":"25","author":"TQ Tan","year":"2012","unstructured":"Tan TQ . Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines. Clin Microbiol Rev 2012;25:409\u201319.","journal-title":"Clin Microbiol Rev"},{"key":"BFpr201739_CR11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/00006454-200204000-00004","volume":"21","author":"GE Schutze","year":"2002","unstructured":"Schutze GE, Mason EO Jr., Barson WJ et al, Invasive pneumococcal infections in children with asplenia. Pediatr Infect Dis J 2002;21:278\u201382.","journal-title":"Pediatr Infect Dis J"},{"key":"BFpr201739_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.7774\/cevr.2015.4.2.121","volume":"4","author":"SH Wei","year":"2015","unstructured":"Wei SH, Chiang CS, Chen CL, Chiu CH . Pneumococcal disease and use of pneumococcal vaccines in Taiwan. Clin Exp Vaccine Res 2015;4:121\u20139.","journal-title":"Clin Exp Vaccine Res"},{"key":"BFpr201739_CR13","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/jama.2012.31377","volume":"309","author":"NM Bennett","year":"2013","unstructured":"Bennett NM, Whitney CG, Moore M, Pilishvili T, Dooling KL . Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP) (Reprinted from MMWR vol 40, pg 816, 2012). JAMA 2013;309:334\u20136.","journal-title":"JAMA"},{"key":"BFpr201739_CR14","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.vaccine.2014.01.009","volume":"32","author":"CL Lu","year":"2014","unstructured":"Lu CL, Chang SY, Chuang YC et al, Revaccination with 7-valent pneumococcal conjugate vaccine elicits better serologic response than 23-valent pneumococcal polysaccharide vaccine in HIV-infected adult patients who have undergone primary vaccination with 23-valent pneumococcal polysaccharide vaccine in the era of combination antiretroviral therapy. Vaccine 2014;32:1031\u20135.","journal-title":"Vaccine"},{"key":"BFpr201739_CR15","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1084\/jem.20022020","volume":"197","author":"S Kruetzmann","year":"2003","unstructured":"Kruetzmann S, Rosado MM, Weber H et al, Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med 2003;197:939\u201345.","journal-title":"J Exp Med"},{"key":"BFpr201739_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/pr.2015.221","volume":"79","author":"SN Chiu","year":"2015","unstructured":"Chiu SN, Shao PL, Wang JK et al, Low immunoglobulin M memory B-cell percentage in patients with heterotaxy syndrome correlates with the risk of severe bacterial infection. Pediatr Res 2015;79:271\u20137.","journal-title":"Pediatr Res"},{"key":"BFpr201739_CR17","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.vaccine.2015.02.026","volume":"33","author":"P Nived","year":"2015","unstructured":"Nived P, Jorgensen CS, Settergren B . Vaccination status and immune response to 13-valent pneumococcal conjugate vaccine in asplenic individuals. Vaccine 2015;33:1688\u201394.","journal-title":"Vaccine"},{"key":"BFpr201739_CR18","first-page":"64","volume":"927","author":"WHO","year":"2005","unstructured":"WHO. Recommendations for the productionand control of pneumococcal conjugate vaccines. World Health Tech Rep Ser 2005;927:64\u201398.","journal-title":"World Health Tech Rep Ser"},{"key":"BFpr201739_CR19","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1093\/cid\/ciu002","volume":"58","author":"O Ochoa-Gondar","year":"2014","unstructured":"Ochoa-Gondar O, Vila-Corcoles A, Rodriguez-Blanco T et al, Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged >= 60 years: 3 years of follow-up in the CAPAMIS Study. Clin. Infect. Dis. 2014;58:909\u201317.","journal-title":"Clin. Infect. Dis."},{"key":"BFpr201739_CR20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jinf.2014.06.006","volume":"69","author":"C Feldman","year":"2014","unstructured":"Feldman C, Anderson R . Review: current and new generation pneumococcal vaccines. J Infect 2014;69:309\u201325.","journal-title":"J Infect"},{"issue":"Suppl 5","key":"BFpr201739_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1469-0691.2012.03938.x","volume":"18","author":"LF Pittet","year":"2012","unstructured":"Pittet LF, Posfay-Barbe KM . Pneumococcal vaccines for children: a global public health priority. Clin Microbiol Infect 2012;18 (Suppl 5): 25\u201336.","journal-title":"Clin Microbiol Infect"},{"key":"BFpr201739_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1086\/648593","volume":"201","author":"T Pilishvili","year":"2010","unstructured":"Pilishvili T, Lexau C, Farley MM et al, Surveillance ABC. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010;201:32\u201341.","journal-title":"J Infect Dis"},{"key":"BFpr201739_CR23","doi-asserted-by":"publisher","first-page":"5513","DOI":"10.1016\/j.vaccine.2009.06.091","volume":"27","author":"YC Hsieh","year":"2009","unstructured":"Hsieh YC, Lin PY, Chiu CH et al, National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19\u2009A with high invasive potential. Vaccine 2009;27:5513\u20138.","journal-title":"Vaccine"},{"key":"BFpr201739_CR24","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/j.1469-0691.2009.02743.x","volume":"15","author":"YC Hsieh","year":"2009","unstructured":"Hsieh YC, Huang YC, Lin HC et al, Characterization of invasive isolates of Streptococcus pneumoniae among Taiwanese children. Clin Microbiol Infect 2009;15:991\u20136.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"BFpr201739_CR25","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.vaccine.2013.11.029","volume":"32","author":"Sigurveig Th. Sigurdardottir","year":"2014","unstructured":"Sigurdardottir ST, Center KJ, Davidsdottir K, Arason VA, Hjalmarsson B, Elisdottir R, Ingolfsdottir G, Northington R, Scott DA, Jonsdottir I 2014 Decreased immune response to pneumococcal conjugate vaccine after 23-valent pneumococcal polysaccharide vaccine in children. Vaccine 32:417\u2013424.","journal-title":"Vaccine"},{"key":"BFpr201739_CR26","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s10096-008-0523-5","volume":"27","author":"B Mikoluc","year":"2008","unstructured":"Mikoluc B, Kayhty H, Bernatowska E, Motkowski R . Immune response to the 7-valent pneumococcal conjugate vaccine in 30 asplenic children. Eur J Clin Microbiol Infect Dis 2008;27:923\u20138.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"BFpr201739_CR27","doi-asserted-by":"publisher","first-page":"5278","DOI":"10.1016\/j.vaccine.2007.05.014","volume":"25","author":"F Smets","year":"2007","unstructured":"Smets F, Bourgois A, Vermylen C et al, Randomised revaccination with pneumococcal polysaccharide or conjugate vaccine in asplenic children previously vaccinated with polysaccharide vaccine. Vaccine 2007;25:5278\u201382.","journal-title":"Vaccine"},{"key":"BFpr201739_CR28","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.4049\/jimmunol.181.5.3684","volume":"181","author":"H Wasserstrom","year":"2008","unstructured":"Wasserstrom H, Bussel J, Lim LC, Cunningham-Rundles C . Memory B cells and pneumococcal antibody after splenectomy. J Immunol 2008;181:3684\u20139.","journal-title":"J Immunol"},{"key":"BFpr201739_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4161\/hv.5.2.6557","volume":"5","author":"E Stanford","year":"2009","unstructured":"Stanford E, Print F, Falconer M et al, Immune response to pneumococcal conjugate vaccination in asplenic individuals. Hum Vaccin 2009;5:85\u201391.","journal-title":"Hum Vaccin"},{"key":"BFpr201739_CR30","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/S0929-6646(09)60148-0","volume":"105","author":"PL Shao","year":"2006","unstructured":"Shao PL, Lu CY, Chang LY et al, Safety and immunogenicity of heptavalent pneumococcal conjugate vaccine booster in Taiwanese toddlers. J Formos Med Assoc 2006;105:542\u20139.","journal-title":"J Formos Med Assoc"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr201739.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr201739","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/pr.2017.39","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/pr201739.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:04:28Z","timestamp":1684616668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr201739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,18]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["BFpr201739"],"URL":"https:\/\/doi.org\/10.1038\/pr.2017.39","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,18]]},"assertion":[{"value":"19 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}